Complete Filing Data
SURO CAPITAL CORP. reported Unrealized Gain Loss On Investments of $32.11 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SURO CAPITAL CORP. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | $48.8M | -$38.1M | $5.1M | -$132.2M | $147.1M | $75.3M |
| Operating Expenses | $18.2M | $18.6M | $20.0M | $18.2M | $11.4M | $16.3M |
| Compensation Expense Excluding Cost Of Good And Service Sold | $8.8M | $9.2M | $9.5M | $7.6M | $6.2M | $8.8M |
| Income Tax Expense Benefit | -$190.8K | $88.7K | $624.0K | $82.2K | $9.3K | $43.6K |
| Income Taxes Paid Net | -$190.8K | $88.7K | $533.9K | $82.2K | $43.5K | $5.9K |
| Interest Expense Operating | $5.1M | $4.8M | $4.9M | $4.8M | ||
| Interest Expense | $4.9M | $4.8M | $693.5K | $2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$20.1M | $7.4M | $62.3M | -$806.7K | $44.5K | -$5.5M | -$10.7M | -$22.1M | -$9.1M | $25.2M | -$15.6M | $4.6M | -$12.4M | -$45.9M | -$94.3M | $20.5M | -$9.5M | $15.2M | $33.4M | $108.0M | $61.3M | $15.9M | $21.8M | -$23.7M |
| Operating Expenses | $6.2M | $3.9M | $3.9M | $4.2M | $5.1M | $4.1M | $4.7M | $4.8M | $5.2M | $4.1M | $5.2M | $5.5M | $4.3M | $4.3M | $4.7M | $4.8M | $3.2M | $2.7M | $2.3M | $3.1M | $5.2M | $3.0M | $4.9M | $3.3M |
| Compensation Expense Excluding Cost Of Good And Service Sold | $1.7M | $1.6M | $1.7M | $1.9M | $2.2M | $2.2M | $2.1M | $2.1M | $2.1M | $1.8M | $1.8M | $1.9M | $1.5M | |||||||||||
| Income Tax Expense Benefit | -$218.7K | $2.8K | $52.8K | $2.1K | $90.8K | $529.8K | $74.5K | $5.7K | $2.1K | -$2.0K | ||||||||||||||
| Income Taxes Paid Net | $2.8K | $2.1K | $4.3K | $2.1K | ||||||||||||||||||||
| Interest Expense Operating | $1.3M | $1.3M | $1.3M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | ||||||||||||||||
| Interest Expense | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Unrealized Gain Loss On Investments | $32.1M | -$19.0M | $30.5M | -$111.6M | -$61.7M | $73.4M | ||
| Assets Net | $205.3M | $157.6M | $203.4M | $210.0M | $364.8M | $301.6M | $199.9M | $195.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $49.1M | $20.0M | $28.2M | $40.1M | $198.4M | $45.8M | $44.9M | |
| Stockholders Equity Period Increase Decrease | $47.7M | -$45.8M | -$6.7M | -$154.8M | $63.3M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $29.0M | -$8.1M | -$11.9M | -$158.3M | $152.6M | $932.5K | ||
| Adjustments To Escrow Proceeds Receivable | -$45.3K | -$331.8K | $117.1K | -$859.1K | $1.9M | $844.8K | ||
| Purchases Of Portfolio Investments | $12.1M | $75.1M | $24.5M | $22.8M | $81.7M | $31.4M | ||
| Amortization Of Debt Discount Premium | $244.0K | $469.0K | $319.1K | $425.6K | $16.3K | |||
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | $205.3M | $157.6M | $203.4M | $210.0M | $364.8M | |||
| Prepaid Expense And Other Assets | $807.3K | $855.6K | $494.6K | $727.0K | $938.0K | |||
| Liabilities | $70.7M | $74.0M | $74.2M | $74.4M | $97.5M | |||
| Investment Owned Percent Of Net Assets | $1.10 | $1.33 | $0.91 | $0.75 | $0.71 | |||
| Interest And Dividends Receivable | $118.7K | $756.0K | $132.6K | $138.8K | $83.7K | |||
| Deferred Costs Current And Noncurrent | $508.3K | $526.3K | $594.7K | $555.8K | $621.7K | |||
| Debt Instrument Interest Rate Stated Percentage | 6.0% | 6.0% | 6.0% | 6.0% | 6.0% | |||
| Debt Instrument Interest Rate Effective Percentage | 7.1% | 6.5% | 6.5% | 6.5% | 6.1% | |||
| Debt Instrument Face Amount | $35.8M | $44.7M | $75.0M | $75.0M | $75.0M | |||
| Common Stock Value | $253.8K | $236.0K | $254.5K | $284.3K | $311.2K | |||
| Assets | $276.0M | $231.6M | $277.6M | $284.4M | $462.3M | |||
| Accumulated Net Unrealized Depreciation Appreciation Of Investments | -$15.3M | -$47.5M | -$28.7M | -$58.9M | $52.7M | |||
| Accumulated Net Realized Gain On Investments Net Of Distributions | $6.9M | -$17.4M | -$12.3M | $2.6M | $11.9M | |||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $627.5K | $768.4K | $346.3K | $708.8K | $875.0K | |||
| Dividends Payable Current And Noncurrent | $301.3K | $8.9K | $152.5K | $296.2K | $23.4M | |||
| Escrow Proceeds Receivable | $45.3K | $309.3K | $628.3K | $2.0M | ||||
| Notes Payable | $35.6M | $44.2M | $73.7M | $73.4M | ||||
| Investments | $209.4M | $247.9M | $242.2M | $260.1M | ||||
| Purchases Of US Treasury Bills Investments | $253.6M | $184.2M | $450.0M | |||||
| Accrued Interest On US Treasury Bills | -$18.2K | -$13.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unrealized Gain Loss On Investments | -$21.3M | $5.7M | $44.8M | $2.9M | -$5.2M | $11.6M | -$7.0M | -$18.4M | -$9.0M | $29.3M | $1.5M | $8.6M | -$7.6M | -$37.0M | -$88.6M | $21.6M | -$53.1M | -$15.0M | $7.7M | -$1.3M | $58.4M | $16.1M | $26.5M | -$27.7M |
| Assets Net | $231.8M | $219.4M | $156.8M | $157.4M | $162.3M | $181.7M | $212.0M | $186.7M | $215.0M | $221.8M | $280.2M | $380.7M | $425.8M | $439.6M | $436.0M | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $54.6M | $49.9M | $16.2M | $32.7M | $54.4M | $50.8M | $73.5M | $24.5M | $48.1M | $39.7M | $153.0M | $172.8M | $108.2M | |||||||||||
| Stockholders Equity Period Increase Decrease | $12.4M | $62.6M | -$767.9K | -$4.9M | -$19.4M | -$21.6M | $25.3M | -$28.4M | $5.0M | -$58.4M | -$100.5M | $15.9M | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.9M | $22.6M | $8.0M | -$25.6M | ||||||||||||||||||||
| Adjustments To Escrow Proceeds Receivable | -$18.0K | -$73.0K | $108.4K | $2.8M | ||||||||||||||||||||
| Purchases Of Portfolio Investments | $1.3M | $10.0M | $2.0M | |||||||||||||||||||||
| Amortization Of Debt Discount Premium | $60.9K | $106.1K | $104.9K | $104.9K | ||||||||||||||||||||
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | $231.8M | $219.4M | $156.8M | $157.4M | $162.3M | $181.7M | $212.0M | $186.7M | $215.0M | $221.8M | ||||||||||||||
| Prepaid Expense And Other Assets | $890.1K | $703.3K | $896.2K | $971.4K | $282.6K | $467.1K | $693.7K | $485.2K | $654.2K | $889.2K | ||||||||||||||
| Liabilities | $76.5M | $75.6M | $74.9M | $76.3M | $76.0M | $75.1M | $77.0M | $76.3M | $76.1M | $77.1M | ||||||||||||||
| Investment Owned Percent Of Net Assets | $1.09 | $1.11 | $1.36 | $1.27 | $1.13 | $0.96 | $0.91 | $0.86 | $0.77 | $0.71 | ||||||||||||||
| Interest And Dividends Receivable | $111.0K | $104.1K | $447.5K | $89.0K | $83.8K | $137.7K | $100.9K | $119.5K | $105.0K | $119.6K | ||||||||||||||
| Deferred Costs Current And Noncurrent | $517.5K | $555.7K | $538.4K | $493.0K | $561.1K | $577.9K | $611.7K | $590.4K | $539.1K | $572.8K | ||||||||||||||
| Debt Instrument Interest Rate Stated Percentage | 6.0% | 6.0% | 6.0% | 6.0% | 6.0% | 6.0% | 6.0% | 6.0% | 6.0% | 600.0% | ||||||||||||||
| Debt Instrument Interest Rate Effective Percentage | 6.5% | 6.5% | 6.5% | 6.5% | 6.5% | 6.5% | 6.5% | 6.5% | 6.5% | 653.0% | ||||||||||||||
| Debt Instrument Face Amount | $39.7M | $39.7M | $39.7M | $49.7M | $75.0M | $75.0M | $75.0M | $75.0M | $75.0M | $75.0M | ||||||||||||||
| Common Stock Value | $251.2K | $238.9K | $235.5K | $233.8K | $233.8K | $253.5K | $252.1K | $254.0K | $283.4K | $283.3K | ||||||||||||||
| Assets | $308.3M | $295.1M | $231.7M | $233.8M | $238.3M | $256.9M | $289.0M | $263.0M | $291.1M | $298.9M | ||||||||||||||
| Accumulated Net Unrealized Depreciation Appreciation Of Investments | $5.9M | $194.4K | -$44.6M | -$42.5M | -$54.1M | -$47.1M | -$19.5M | -$48.8M | -$50.2M | -$51.2M | ||||||||||||||
| Accumulated Net Realized Gain On Investments Net Of Distributions | $3.0M | $3.8M | -$17.4M | -$26.7M | -$12.8M | -$12.8M | -$12.0M | -$10.5M | $2.7M | $4.4M | ||||||||||||||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $2.9M | $2.3M | $1.6M | $3.0M | $2.0M | $1.3M | $3.2M | $2.5M | $2.4M | $3.4M | ||||||||||||||
| Dividends Payable Current And Noncurrent | $183.1K | $44.7K | $44.7K | $44.7K | $188.4K | $188.4K | $188.4K | $349.9K | ||||||||||||||||
| Escrow Proceeds Receivable | $27.3K | $63.7K | $71.0K | $236.3K | $309.5K | $376.0K | $609.7K | $653.8K | ||||||||||||||||
| Notes Payable | $39.4M | $39.4M | $39.3M | $49.2M | $73.9M | $73.8M | $73.7M | $73.6M | ||||||||||||||||
| Investments | $199.3M | $182.9M | $204.6M | $213.8M | $236.2M | $241.1M | $257.0M | |||||||||||||||||
| Purchases Of US Treasury Bills Investments | $35.5M | |||||||||||||||||||||||
| Accrued Interest On US Treasury Bills | $376.8K | $458.6K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Values Share Based Compensation Gross | $569.7K | $1.7M | $2.4M | $2.0M | $1.3M | $2.0M |
| Share Based Compensation | $569.7K | $1.7M | $2.4M | $2.0M | $1.3M | $2.0M |
| Payments Of Dividends | $12.0M | $143.7K | $143.7K | $26.5M | $103.5M | $14.7M |
| Net Cash Provided By Used In Operating Activities | $34.3M | $2.4M | $2.4M | -$110.6M | $183.7M | -$23.6M |
| Net Cash Provided By Used In Financing Activities | -$5.3M | -$10.5M | -$14.3M | -$47.8M | -$31.0M | $24.6M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$48.3K | $361.0K | -$232.4K | -$211.0K | -$47.6K | -$770.4K |
| Increase Decrease In Interest And Dividends Receivable | -$637.3K | $623.4K | -$6.2K | $55.1K | -$83.3K | $82.4K |
| Increase Decrease In Escrow Proceeds Receivable | -$45.3K | -$264.0K | -$319.0K | -$1.4M | $1.2M | $587.2K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$140.9K | $422.1K | -$362.5K | -$166.2K | $112.7K | -$381.6K |
| Proceeds From Sales Or Maturity Of Investments Portfolio Investments | $61.3M | $26.1M | $16.0M | $9.1M | $257.4M | $31.2M |
| Proceeds From Sales Or Maturity Of Investments US Treasury Bills | $63.8M | $274.8M | $99.2M | $150.0M | $350.0M | |
| Payments For Repurchase Of Common Stock | $9.4M | $14.2M | $21.5M | $10.4M | ||
| Payments Of Financing Costs | $30.2K | $53.7K | $1.5K | $366.2K | $285.8K | |
| Proceeds From Issuance Of Common Stock | $10.6M | $229.9K | $78.6K | $49.9M | ||
| Increase Decrease In Proceeds Receivable | -$52.5K | $52.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Values Share Based Compensation Gross | $375.7K | $277.4K | $38.8K | $577.3K | $642.2K | $428.8K | $763.6K | $769.7K | $405.9K | $713.4K | $703.6K | -$30.0K | $148.8K |
| Share Based Compensation | $38.8K | $428.8K | $405.9K | -$30.0K | |||||||||
| Payments Of Dividends | $8.9K | $107.8K | $107.8K | $23.1M | |||||||||
| Net Cash Provided By Used In Operating Activities | -$3.7M | $22.7M | $8.1M | -$1.4M | |||||||||
| Net Cash Provided By Used In Financing Activities | -$136.0K | -$107.8K | -$107.8K | -$24.2M | |||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $40.5K | -$27.5K | -$72.8K | -$147.8K | |||||||||
| Increase Decrease In Interest And Dividends Receivable | -$308.5K | $5.1K | -$33.8K | $4.2K | |||||||||
| Increase Decrease In Escrow Proceeds Receivable | -$18.0K | -$73.0K | -$18.6K | $2.5M | |||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $840.8K | $924.3K | $1.7M | $774.3K | |||||||||
| Proceeds From Sales Or Maturity Of Investments Portfolio Investments | $318.3K | $2.9M | $1.3M | ||||||||||
| Proceeds From Sales Or Maturity Of Investments US Treasury Bills | $34.5M | $45.0M | |||||||||||
| Payments For Repurchase Of Common Stock | $1.4M | ||||||||||||
| Payments Of Financing Costs | $29.9K | $1.5K | |||||||||||
| Proceeds From Issuance Of Common Stock | $229.9K | ||||||||||||
| Increase Decrease In Proceeds Receivable | -$52.5K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 28.8M | 23.9M | 26.2M | 30.0M | 26.8M | 21.8M | |||
| Weighted Average Number Of Shares Outstanding Basic | 24.2M | 23.9M | 26.2M | 30.0M | 25.9M | 17.9M | |||
| Earnings Per Share Diluted | $1.78 | $-1.60 | $0.19 | $-4.40 | $5.52 | $3.56 | |||
| Earnings Per Share Basic | $2.01 | $-1.60 | $0.19 | $-4.40 | $5.69 | $4.21 | |||
| Net Asset Value Per Share | $8.09 | $6.68 | $7.99 | $7.39 | $11.72 | $15.14 | $11.38 | $9.89 | $9.64 |
| Shares Outstanding | 25.4M | 23.6M | 25.4M | 28.4M | 31.1M | 19.9M | 17.6M | 19.8M | |
| Common Stock Shares Outstanding | 25.4M | 23.6M | 28.4M | 31.1M | |||||
| Common Stock Shares Issued | 25.4M | 23.6M | 25.4M | 28.4M | 31.1M | ||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 25.2M | 29.0M | 28.2M | 23.6M | 23.4M | 23.4M | 23.4M | 25.4M | 25.3M | 25.4M | 26.0M | 28.4M | 28.3M | 29.8M | 30.6M | 31.2M | 29.9M | 27.6M | 25.3M | 24.1M | 23.9M | 21.6M | 20.3M | 17.4M |
| Weighted Average Number Of Shares Outstanding Basic | 25.2M | 24.4M | 23.7M | 23.6M | 23.4M | 23.4M | 23.4M | 25.4M | 25.3M | 25.4M | 26.0M | 28.4M | 28.3M | 29.8M | 30.6M | 31.2M | 29.9M | 27.6M | 25.3M | 20.5M | 20.0M | 17.8M | 16.4M | 17.4M |
| Earnings Per Share Diluted | $-0.80 | $0.28 | $2.23 | $-0.03 | $-0.23 | $-0.45 | $-0.87 | $-0.36 | $0.99 | $-0.60 | $0.16 | $-0.44 | $-1.54 | $-3.08 | $0.66 | $-0.32 | $0.55 | $1.32 | $4.50 | $2.59 | $0.76 | $1.10 | $-1.36 | |
| Earnings Per Share Basic | $-0.80 | $0.30 | $2.63 | $-0.03 | $-0.23 | $-0.45 | $-0.87 | $-0.36 | $0.99 | $-0.60 | $0.16 | $-0.44 | $-1.54 | $-3.08 | $0.66 | $-0.32 | $0.55 | $1.32 | $5.27 | $3.06 | $0.89 | $1.33 | $-1.36 | |
| Net Asset Value Per Share | $9.23 | $9.18 | $6.66 | $6.73 | $6.94 | $7.17 | $8.41 | $7.35 | $7.59 | $7.83 | $9.24 | $12.22 | $14.79 | $16.56 | ||||||||||
| Shares Outstanding | 23.9M | 23.6M | 23.4M | 23.4M | 25.4M | 25.2M | 25.4M | 28.3M | 28.3M | 30.3M | 31.2M | 28.8M | ||||||||||||
| Common Stock Shares Outstanding | 25.1M | 23.9M | 23.6M | 23.4M | 23.4M | 25.4M | 25.4M | 25.2M | 25.4M | 28.3M | 28.3M | |||||||||||||
| Common Stock Shares Issued | 25.1M | 23.9M | 23.6M | 23.4M | 23.4M | 25.4M | 25.2M | 25.4M | 28.3M | 28.3M | ||||||||||||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | ||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Realized Investment Gains Losses | $33.2M | -$5.0M | -$11.9M | -$5.9M | $218.7M | $16.4M |
| Net Investment Income | -$16.5M | -$14.0M | -$13.4M | -$14.7M | -$9.9M | -$14.5M |
| Investment Income Net | $6.6M | $3.5M | $1.5M | $1.8M | ||
| Investment Company Capital Share Transactions | $11.2M | -$7.7M | -$11.7M | -$19.2M | $128.4M | $43.3M |
| Professional Fees | $2.2M | $2.3M | $2.6M | $3.4M | $2.7M | $3.0M |
| Other Expenses | $1.4M | $1.6M | $1.8M | $1.6M | $1.1M | $1.8M |
| Directors Fees | $789.4K | $682.3K | $645.5K | $675.7K | $752.4K | $445.0K |
| Realized Investment Gain Losses | $33.2M | -$5.0M | -$11.9M | -$5.9M | $218.7M | $16.4M |
| Stock Issued During Period Shares Restricted Stock Award Gross | 538.6K | 155.8K | 202.8K | 301.8K | 369.3K | 21.8K |
| Interest Paid Net | $4.6M | $4.4M | $4.5M | $4.7M | $794.2K | $1.9M |
| Stock Repurchased During Period Value | $9.4M | $14.2M | $21.5M | $10.4M | ||
| Investment Owned At Fair Value | $225.5M | $209.4M | $184.1M | $157.2M | $260.1M | |
| Additional Paid In Capital | $217.5M | $226.6M | $248.5M | $330.9M | $350.1M | |
| Accumulated Net Investment Loss | -$4.0M | -$4.3M | -$4.3M | -$64.8M | -$50.1M | |
| Stock Repurchased For Capital Share Activity | -$2.0M | -$3.2M | -$3.0M | -$1.7M | ||
| Investment Company Dividend Distribution | $12.3M | $3.4M | $212.2M | $16.9M | ||
| Investment Company Dividend Declared | $12.3M | $3.4M | $212.2M | $16.9M | ||
| Stock Issued During Period Shares New Issues | 1.2M | 17.8K | 5.9K | 3.8M | ||
| Investment Income Interest And Dividend | $1.7M | $4.7M | $6.6M | $3.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Realized Investment Gains Losses | $6.8M | $5.2M | $21.2M | -$18.0K | $9.1M | -$13.7M | -$29.6K | -$424.1K | $2.6M | -$1.5M | -$13.3M | $189.3K | -$1.9M | -$5.1M | -$2.0M | $3.1M | $46.4M | $32.5M | $27.7M | $112.2M | $7.1M | $2.4M | -$24.0K | $7.0M |
| Net Investment Income | -$5.7M | -$3.5M | -$3.7M | -$3.7M | -$3.9M | -$3.2M | -$3.7M | -$3.2M | -$2.7M | -$2.7M | -$3.8M | -$4.2M | -$2.9M | -$3.8M | -$3.8M | -$4.2M | -$2.8M | -$2.2M | -$2.0M | -$2.8M | -$4.3M | -$2.6M | -$4.7M | -$3.0M |
| Investment Income Net | $888.7K | $1.0M | $1.5M | $2.5M | $1.5M | $1.4M | $1.3M | $1.5M | $519.5K | $890.6K | $583.1K | $380.8K | $523.9K | $274.8K | $291.4K | $922.7K | $408.1K | $241.5K | $251.8K | |||||
| Investment Company Capital Share Transactions | $10.9M | $277.4K | $38.8K | $577.3K | -$8.8M | $428.8K | $85.0K | -$12.7M | $405.9K | -$12.5M | -$6.2M | -$1.2M | $30.7M | $30.8M | $37.4M | |||||||||
| Professional Fees | $394.2K | $680.9K | $750.2K | $515.2K | $586.8K | $728.6K | $277.1K | $916.6K | $990.8K | $565.4K | $1.1M | $1.3M | $604.5K | |||||||||||
| Other Expenses | $318.0K | $404.5K | $309.6K | $339.9K | $462.8K | $449.6K | $356.5K | $676.4K | $489.6K | $487.6K | $439.5K | $311.0K | $276.6K | |||||||||||
| Directors Fees | $246.7K | $175.5K | $170.6K | $171.7K | $167.8K | $171.1K | $161.7K | $161.7K | $160.6K | $161.7K | $191.8K | $160.6K | $368.3K | |||||||||||
| Realized Investment Gain Losses | -$18.0K | -$424.1K | $189.3K | $3.1M | ||||||||||||||||||||
| Stock Issued During Period Shares Restricted Stock Award Gross | 49.7K | 92.5K | 90.9K | 181.6K | ||||||||||||||||||||
| Interest Paid Net | $1.2M | $1.1M | $1.1M | $1.3M | ||||||||||||||||||||
| Stock Repurchased During Period Value | $9.4M | $678.7K | $13.5M | $13.2M | $6.9M | $1.4M | ||||||||||||||||||
| Investment Owned At Fair Value | $252.2M | $243.8M | $213.6M | $199.3M | $182.9M | $175.0M | $193.5M | $160.3M | $165.1M | $157.7M | ||||||||||||||
| Additional Paid In Capital | $237.8M | $226.9M | $226.6M | $240.7M | $240.1M | $248.9M | $318.7M | $318.6M | $331.3M | $330.3M | ||||||||||||||
| Accumulated Net Investment Loss | -$15.1M | -$11.7M | -$8.0M | -$14.4M | -$11.2M | -$7.5M | -$75.5M | -$72.9M | -$69.1M | -$62.0M | ||||||||||||||
| Stock Repurchased For Capital Share Activity | -$153.5K | |||||||||||||||||||||||
| Investment Company Dividend Distribution | $6.0M | $3.4M | $59.8M | $60.5M | $11.0M | |||||||||||||||||||
| Investment Company Dividend Declared | $3.4M | $59.8M | $60.5M | $11.0M | ||||||||||||||||||||
| Stock Issued During Period Shares New Issues | 10.6M | 17.8K | ||||||||||||||||||||||
| Investment Income Interest And Dividend | $459.3K | $167.3K | $499.1K | $888.7K | $1.0M | $1.5M |
Most recent annual filing with the SEC: March 11, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.